Weiya Pei
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- IL-33, ST2, and ILC Pathways 3
-
- Extracellular vesicles in disease 4
- Co-authors
- Kun Lv (7 shared papers)Xueqin Li (6 shared papers)Xiaolong Zhu (6 shared papers)Min Zhong (3 shared papers)Mengying Zhang (4 shared papers)Chuanlai Shen (7 shared papers)Khawar Ali Shahzad (7 shared papers)Xin Wan (7 shared papers)
- Journals
- International Immunopharmacology (2 papers)Immunological Investigations (2 papers)The FASEB Journal (1 paper)Drug Delivery (1 paper)BMC Pulmonary Medicine (1 paper)
- Partner nations
- ChinaBangladeshPakistan
In The Last Decade
Weiya Pei
19 papers receiving 516 citations
Weiya Pei's Hit Papers
Peers
Comparison fields: 5 of 83
- Immunology 176
- Cancer Research 77
- Pharmaceutical Science 23
- Molecular Biology 218
- Biomaterials 37
Countries citing papers authored by Weiya Pei
This map shows the geographic impact of Weiya Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiya Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiya Pei more than expected).
Fields of papers citing papers by Weiya Pei
This network shows the impact of papers produced by Weiya Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiya Pei. The network helps show where Weiya Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiya Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 91 | |
| 2 | 2021 | 79 | |
| 3 | Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles Hit paper breakdown → | 2024 | 72 |
| 4 | 2018 | 37 | |
| 5 | 2020 | 35 | |
| 6 | 2020 | 34 | |
| 7 | 2018 | 25 | |
| 8 | 2022 | 25 | |
| 9 | 2017 | 24 | |
| 10 | 2020 | 21 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2023 | 9 | |
| 15 | 2017 | 6 | |
| 16 | 2025 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2021 | 3 | |
| 19 | 2020 | 1 |
About Weiya Pei
Weiya Pei is a scholar working on Immunology, Molecular Biology, Surgery, Cancer Research and Automotive Engineering, having authored 19 papers that have together received 516 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers), Extracellular vesicles in disease (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Soil Mechanics and Vehicle Dynamics (2 papers), Viral Infections and Immunology Research (2 papers) and Vehicle Dynamics and Control Systems (2 papers). The work is most often cited by research in Immunology (176 citations), Cancer Research (77 citations), Pharmaceutical Science (23 citations), Molecular Biology (218 citations) and Biomaterials (37 citations). Weiya Pei has collaborated with scholars based in China, Bangladesh and Pakistan. Frequent co-authors include Kun Lv, Xueqin Li, Xiaolong Zhu, Min Zhong, Mengying Zhang, Chuanlai Shen, Khawar Ali Shahzad, Xin Wan, Hui Yang and Liangyu Zhu. Their work appears in journals such as International Immunopharmacology, Immunological Investigations, The FASEB Journal, Drug Delivery and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.